Ancient herbs meet AI: could a TCM formula slow kidney failure in diabetes?
NCT ID NCT07459946
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a Traditional Chinese Medicine (TCM) herbal formula, Jiajian Yishen Xiaozheng Qufeng Granules, combined with AI-driven diagnostics to treat diabetic nephropathy (kidney disease from type 2 diabetes). About 198 adults with mild-to-moderate kidney damage will receive the formula or a placebo in a double-blind trial. The goal is to see if the treatment can reduce protein in urine and slow kidney decline, potentially improving patients' quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Jiajian Yishen Xiaozheng Qufeng Granules (a Traditional Chinese Medicine formula)
- What this could lead to
- If successful, this could offer a new, non-drug treatment option to slow kidney disease progression and improve quality of life for people with diabetic nephropathy.
- What could go wrong
- This is an early-stage trial with only 198 participants, and the herbal formula is unlisted in standard drug databases. Results may not apply to all patients, and the treatment's safety and effectiveness are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RENAL FAILURE/ KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.